{"title":"药物不良反应和社交媒体","authors":"C. Anton","doi":"10.1097/FAD.0000000000000004","DOIUrl":null,"url":null,"abstract":"SummaryThe recent explosion in the use of social media has led to a rapidly changing landscape in pharmacovigilance. More and more patients are content to share health information online and often on entirely open access sites. Such information remains mostly untapped and there are questions as to its usefulness in generating signals of emerging drug safety issues.","PeriodicalId":39261,"journal":{"name":"Adverse Drug Reaction Bulletin","volume":"286 1","pages":"1103–1106"},"PeriodicalIF":0.0000,"publicationDate":"2014-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/FAD.0000000000000004","citationCount":"1","resultStr":"{\"title\":\"Adverse drug reactions and social media\",\"authors\":\"C. Anton\",\"doi\":\"10.1097/FAD.0000000000000004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"SummaryThe recent explosion in the use of social media has led to a rapidly changing landscape in pharmacovigilance. More and more patients are content to share health information online and often on entirely open access sites. Such information remains mostly untapped and there are questions as to its usefulness in generating signals of emerging drug safety issues.\",\"PeriodicalId\":39261,\"journal\":{\"name\":\"Adverse Drug Reaction Bulletin\",\"volume\":\"286 1\",\"pages\":\"1103–1106\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1097/FAD.0000000000000004\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Adverse Drug Reaction Bulletin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/FAD.0000000000000004\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Adverse Drug Reaction Bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/FAD.0000000000000004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
SummaryThe recent explosion in the use of social media has led to a rapidly changing landscape in pharmacovigilance. More and more patients are content to share health information online and often on entirely open access sites. Such information remains mostly untapped and there are questions as to its usefulness in generating signals of emerging drug safety issues.
期刊介绍:
For over 40 years, Adverse Drug Reaction Bulletin has provided comprehensive coverage in the field of adverse drug reactions. Each issue contains an invited article on a topic of current interest, dealing with specific conditions from drug-induced lung disorders to drug-induced sexual dysfunction, or types of drugs from lipid-lowering agents to poisons antidotes. This bimonthly journal"s articles are timely, succinct and fully referenced